REQUEST A DEMO
Total
USD $0.00
Search more companies

Genome & Company Ltd. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Genome & Company Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a company mainly engaged in the research, development, manufacturing and sale of probiotics. Probiotics are mainly used in products including immune oncology therapeutic supplements, dietary supplements, cosmetics and medicines. These products are mainly applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies. The Company was founded on September 24, 2015 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 26, 2018.

Headquarters
35, Pangyo-Ro 255Beon-Gil, Undang-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;

Contact Details: Purchase the Genome & Company Ltd. report to view the information.

Website: http://genomecom.co.kr

Basic Information
Total Employees:
Purchase the Genome & Company Ltd. report to view the information.
Outstanding Shares:
Purchase the Genome & Company Ltd. report to view the information.
Registered Capital:
Purchase the Genome & Company Ltd. report to view the information.
Financial Auditors:
Purchase the Genome & Company Ltd. report to view the information.
Incorporation Date:
September 24, 2015
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Ownership Details
Purchase this report to view the information.
26%
Purchase this report to view the information.
24.9%
Purchase this report to view the information.
10.4%
Subsidiaries
Genome And Company
Company Performance
Financial values in the chart are available after Genome & Company Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
67.37%
Total operating revenue
68.53%
Operating profit (EBIT)
25.66%
EBITDA
34.7%
Net Profit (Loss) for the Period
23.04%
Total assets
-3.53%
Total equity
-23.21%
Operating Profit Margin (ROS)
270.82%
Net Profit Margin
240.25%
Return on Equity (ROE)
-0.02%
Debt to Equity Ratio
19.78%
Quick Ratio
-8.46%
Cash Ratio
-5.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?